Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Managing cardiometabolic risk in women with gestational diabetes using continuous glucose monitoring and mobile health

Official title: The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus: The Development and Application of "a Lifestyle Intervention Based on Health Belief Model Supported by Mobile Health"

Run by National Taiwan University Hospital · NCT06648174 · Data updated 2026-11-12

This trial will test whether continuous glucose monitoring plus a mobile health lifestyle program helps pregnant women with gestational diabetes control blood sugar and lower cardiometabolic risk for them and their babies.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment120 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Hsinchu)
StatusRecruiting
StartedNovember 11, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT06648174 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women aged 18 or older diagnosed with gestational diabetes who can attend study visits at the Hsinchu site and are willing to use CGM and mobile health tools are ideal candidates.

Probably not a fit

Women with preexisting diabetes, known tape allergies, abnormal coagulation, or those unable or unwilling to use CGM or mobile technology may not receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 120 pregnant women with gestational diabetes in Hsinchu, Taiwan and randomly assign them to routine finger‑prick monitoring, continuous glucose monitoring (CGM) alone, or CGM plus a health belief model–based lifestyle and mHealth program delivered from mid‑pregnancy through the postpartum period. The behavioral intervention is family‑centered and delivered via mobile health at 24–32 weeks, continued until delivery, with follow-up at 4–12 weeks postpartum. Outcomes measured at baseline, late pregnancy, and postpartum include maternal glycemic parameters, cardiometabolic risk markers, health behaviors, and infant outcomes. The trial will compare changes across the three arms to see if CGM and the added mHealth lifestyle program improve short‑term glucose control and early cardiometabolic indicators.

Why it matters

Potential benefit: If successful, the combined CGM plus mHealth lifestyle program could improve blood sugar control during and after pregnancy, reduce mothers' early cardiometabolic risk, and improve infant outcomes.

How similar studies have gone: Previous work shows CGM can improve short‑term glucose control in gestational diabetes, but evidence is limited on long‑term cardiometabolic benefit and on combining CGM with an HBM‑based mHealth lifestyle program across pregnancy and postpartum.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 18 years or above
2. Pregnant women diagnosed with gestational diabetes mellitus
3. Willing to participate in the study

Exclusion Criteria:

1. Diagnosed with diabetes mellitus before pregnancy
2. Allergic to materials such as tapes (e.g., redness, swelling, itching, pain, blisters, or rashes caused by breathable tapes or patches)
3. Abnormal coagulation function

Where it's running

  • National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
    Hsinchu, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.